Wells Fargo
DWTX

Wells Fargo’s Dogwood Therapeutics DWTX Stock Holding History

Wells Fargo’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$64 – 7566
2024
Q1 		$64 Hold
5
– – ﹤0.01% 6767
2023
Q4 		$75 Hold
5
– – ﹤0.01% 6837
2023
Q3 		$115 Hold
5
– – ﹤0.01% 6737
2023
Q2 		$171 Hold
5
– – ﹤0.01% 6745
2023
Q1 		$44 Hold
5
– – ﹤0.01% 7144
2022
Q4 		$28 Buy
5
+3
+150% +$23 ﹤0.01% 7199
2022
Q3 		$0 Hold
2
– – ﹤0.01% 7529
2022
Q2 		$0 Hold
2
– – ﹤0.01% 7652
2022
Q1 		$0 Hold
2
– – ﹤0.01% 7983
2021
Q4 		$0 Hold
2
– – ﹤0.01% 7934
2021
Q3 		$0 Buy
2
+1
+100% +$138 ﹤0.01% 7636
2021
Q2 		$0 Hold
1
– – ﹤0.01% 7571
2021
Q1 		$0 Buy
+1
New +$174 ﹤0.01% 7497

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo's DWTX Position: Q2 2024 in Review

Wells Fargo sold out of Dogwood Therapeutics (DWTX) in Q2 2024, closing a stake of 5 shares — an estimated $64 sold.

Wells Fargo first reported a position in DWTX in Q1 2021 and held it in 13 quarters. The position peaked at $171 in Q2 2023. 24 funds tracked by Wall St. Rank hold DWTX as of Q2 2024.

  • Wells Fargo reported no remaining Dogwood Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 5 Dogwood Therapeutics shares in Q2 2024, an estimated $64.
  • Wells Fargo first reported a position in Dogwood Therapeutics in Q1 2021 and held it in 13 quarters.
  • Wells Fargo's Dogwood Therapeutics position peaked at $171 in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.